StockData
Tyra Biosciences, Inc. logo

Tyra Biosciences, Inc. (TYRA) stock

TYRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$19.57−0.17 (-0.86%)

Close on Nov 17, 2026Market cap $1.17BP/E –Yield –

Tyra Biosciences total assets

Total assets on the balance sheet at the end of each period.

Tyra Biosciences's total assets was $383.36M at Jun 30, 2026. For fiscal 2025 it was $282.61M, down 22.3% from the year before. The highest annual figure on record is $363.56M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$282.61M-22.3%
FY2024Dec 31, 2024$363.56M+61.0%
FY2023Dec 31, 2023$225.86M-15.1%
FY2022Dec 31, 2022$266.18M-13.2%
FY2021Dec 31, 2021$306.70M+1815.6%
FY2020Dec 31, 2020$16.01M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$383.36M+19.2%
Q1 FY2026Mar 31, 2026$412.04M+20.0%
Q4 FY2025Dec 31, 2025$282.61M-22.3%
Q3 FY2025Sep 30, 2025$301.85M-20.7%
Q2 FY2025Jun 30, 2025$321.50M-18.1%
Q1 FY2025Mar 31, 2025$343.48M-15.1%
Q4 FY2024Dec 31, 2024$363.56M+61.0%
Q3 FY2024Sep 30, 2024$380.59M+59.7%
Q2 FY2024Jun 30, 2024$392.46M+57.0%
Q1 FY2024Mar 31, 2024$404.74M+58.7%
Q4 FY2023Dec 31, 2023$225.86M-15.1%
Q3 FY2023Sep 30, 2023$238.36M-13.6%
Q2 FY2023Jun 30, 2023$250.01M-12.9%
Q1 FY2023Mar 31, 2023$255.06M-14.7%
Q4 FY2022Dec 31, 2022$266.18M-13.2%
Q3 FY2022Sep 30, 2022$275.99M-12.7%
Q2 FY2022Jun 30, 2022$287.12M+1693.3%
Q1 FY2022Mar 31, 2022$298.97M–
Q4 FY2021Dec 31, 2021$306.70M–
Q3 FY2021Sep 30, 2021$315.97M–
Q4 FY2020Dec 31, 2020$16.01M–

More Tyra Biosciences figures

See a number that looks wrong?